In addition, metformin was also found to have anti-tumor effects
31,35-37 Prospective trials are needed to further explore this potential adverse event and worsened DR, which is the central premise of the ophthalmic FOCUS trial that is expected to release results in 2026
Should I wait for the pills? The $149/month oral GLP-1s will change access dramatically
95% CI: 0.030.67), followed in order by dulaglutide (1.04%), liraglutide (1.39%), albiglutide (5.61%), lixisenatide (8.07%), and semaglutide (18.72%)
Mean FPG and glycated hemoglobin (HbA 1c ) decreased significantly with all liraglutide doses versus placebo at year 1 and with liraglutide 2.4/3.0 mg versus orlistat at year 2 (Supplementary Figure 3)
Reduced physical activity in some users